RE:RE:RE:RE:SZLS and CBDT labsmarket cap for CBDT is now almost $500m since that move up yesterday. There is a reason James isn't saying anything we just don't know what it is. Is he even calling the shots now or are the 3 institutions calling the shots? Someone wise once told me that if you ask a question and get no answer then strangely the silence is an answer.
they don't know the answer
they don't want you to know the answer
they don't want the competition to know the answer
and others
we will find out soon enough though. Yes we have all waited many years but what is another 6 weeks?
In my reading about LDT's labs have the option of filing a 510K which basically alerts the FDA to your new test and they then have to look at it. The pro active approach to launch. The worst thing would be for Aristotle to launch and spend M's$ in marketing only to have the FDA pull the plug and say we need 90 days to look at the validation data. Grail and Exas won't be happy to hear of Aristotle launch and will likely be on the phone to the FDA. Not saying SZLS will take that route but it is an option for them. The projected market for tests like Aristotle is huge but it would be nice to be the first and established before the competition is launched.
Launch then market Aristotle is probably the best way to go in my mind. Could they provide a rev update or covid test number update? Sure. But they obviously don't want to. Yet.